Dr. Öğr. Üyesi HAYRANİ EREN BOSTANCI

Makaleler 38

1. New hydrazone derivatives: synthesis, characterization, carbonic anhydrase I-II enzyme inhibition, anticancer activity and in silico studies

ACAR ÇEVİK U., Ünver H., BOSTANCI H. E., TÜZÜN B., Gedik N. I., KOÇYİĞİT Ü. M.

Zeitschrift fur Naturforschung - Section C Journal of Biosciences , cilt.80, sa.11-12, ss.705-718, 2025 (SCI-Expanded, Scopus)

2. Synthesis and in silico study of novel benzimidazole derivatives bearing oxadiazole moiety as potential carbonic anhydrase inhibitors, anticancer and antioxidant agents

BOSTANCI H. E., Maryam Z., Kapavarapu R., BAL H., Bagcı E. R., Celik F. K., et al.

Journal of Molecular Structure , cilt.1342, 2025 (SCI-Expanded)

3. Green Synthesis and Characterization of Silver and Zinc Nanoparticles Using Pyracantha coccinea M. Roem and Their Biological Activities

Gökdere N., Rizvanoğlu S. S., Emir E., BOSTANCI H. E., ERYILMAZ M., Atakol O., et al.

Applied Organometallic Chemistry , cilt.39, sa.10, 2025 (SCI-Expanded)

4. Synthesis and anti-cancer properties of Pd(II) and Pt(II) coordination compounds of heterocyclic Schiff base ligands

Al-Azzawi M., Yılmaz İ., BOSTANCI H. E.

Journal of Molecular Structure , cilt.1337, 2025 (SCI-Expanded)

5. Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus

Kaya B., ACAR ÇEVİK U., Necip A., Duran H. E., ÇİFTCİ B., IŞIK M., et al.

ACS Omega , cilt.10, sa.18, ss.18812-18828, 2025 (SCI-Expanded)

6. New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies

BOSTANCI H. E., Yıldız M. T., KAPANCIK S., ŞAHİN İNAN Z. D., Kılıç H. A., ÖZENSOY GÜLER Ö., et al.

Archiv der Pharmazie , cilt.358, sa.3, 2025 (SCI-Expanded)

7. Novel Benzimidazole-Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies

Çevik U. A., ÇELİK İ., Görgülü Ş., ŞAHİN İNAN Z. D., BOSTANCI H. E., Karayel A., et al.

ACS Omega , cilt.10, sa.7, ss.6801-6813, 2025 (SCI-Expanded)

8. Synthesis, antibacterial, anti-urease, DFT and molecular docking studies of novel bis-1,3,4-thiadiazoles

Kaya B., ACAR ÇEVİK U., Behçet M., Karayel A., Daoud N. E., BOSTANCI H. E., et al.

Journal of Molecular Structure , cilt.1321, 2025 (SCI-Expanded)

9. Synthesis, characterization, antimicrobial, antioxidant, and anti-cancer activity of new hybrid structures based on benzimidazole and thiadiazole

BOSTANCI H. E., Çevik U. A., Işık A., Maryam Z., İNCE U., ÖZKAY Y., et al.

Brazilian Journal of Pharmaceutical Sciences , cilt.61, 2025 (SCI-Expanded)

10. Novel Hydrazide-Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes

Işık A., ACAR ÇEVİK U., ÇELİK İ., Küçükoğlu K., NADAROĞLU H., BOSTANCI H. E., et al.

Chemical Biology and Drug Design , cilt.104, sa.6, 2024 (SCI-Expanded)

11. Synthesis, α-Glucosidase, α-Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2-a]pyridine Derivatives

Kaya B., ACAR ÇEVİK U., ÇİFTCİ B., Duran H. E., TÜRKEŞ C., IŞIK M., et al.

ACS Omega , cilt.9, sa.42, ss.42905-42914, 2024 (SCI-Expanded)

12. In vitro anti-Helicobacter pylori, anti-urease and anti-gastric cancer activities of novel hydrazones

Maryam Z., Kaya B., BOSTANCI H. E., Kısa D., ÇELİK İ., ACAR ÇEVİK U., et al.

Journal of Molecular Structure , cilt.1307, 2024 (SCI-Expanded)

13. New benzimidazole-oxadiazole derivatives as potent VEGFR-2 inhibitors: Synthesis, anticancer evaluation, and docking study

ACAR ÇEVİK U., ÇELİK İ., Görgülü Ş., ŞAHİN İNAN Z. D., BOSTANCI H. E., ÖZKAY Y., et al.

Drug Development Research , cilt.85, sa.4, 2024 (SCI-Expanded)

14. Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I-II Inhibition Properties, and In Silico Studies

Faris M., BOSTANCI H. E., Özcan İ., ÖZTÜRK M., KOÇYİĞİT Ü. M., ERDOĞAN T., et al.

ACS Omega , cilt.9, sa.19, ss.20937-20956, 2024 (SCI-Expanded)

15. Synthesis and Characterization of Oxime Derivatives and their Some Transition Metal Complexes with Thiadiazole Groups: Biological Activities, and Molecular Docking Studies of the Ligands

Otaiwi A. S., Mirghani A. H., BOSTANCI H. E., Coskun A., Tahtaci H., Uysal S.

ChemistrySelect , cilt.9, sa.16, 2024 (SCI-Expanded)

16. Synthesis, DFT Calculations, In Silico Studies, and Antimicrobial Evaluation of Benzimidazole-Thiadiazole Derivatives

Işık A., ACAR ÇEVİK U., Karayel A., Ahmad I., Patel H., ÇELİK İ., et al.

ACS Omega , cilt.9, sa.16, ss.18469-18479, 2024 (SCI-Expanded)

17. Design, synthesis and biological evaluation of novel ketone derivatives containing benzimidazole and 1,3,4-triazole as CA inhibitors

ACAR ÇEVİK U., Işık A., Kapavarapu R., Küçükoğlu K., NADAROĞLU H., BOSTANCI H. E., et al.

Journal of Molecular Structure , cilt.1295, 2024 (SCI-Expanded)

18. Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors

ÇELİK İ., ACAR ÇEVİK U., Küçükoğlu K., NADAROĞLU H., BOSTANCI H. E., Işık A., et al.

Chemical Biology and Drug Design , cilt.103, sa.1, 2024 (SCI-Expanded)

19. Investigation of Antiepileptic and Anticancer Properties of Some Plant Species Traditionally Used in Turkey

ÖZPINAR H., BOSTANCI H. E., Hurmet M., KOÇYİĞİT Ü. M.

Latin American Journal of Pharmacy , cilt.43, sa.3, ss.618-625, 2024 (SCI-Expanded)

20. Imidazole-hydrazone derivatives: Synthesis, characterization, X-ray structures and evaluation of anticancer and carbonic anhydrase I–II inhibition properties

Ünver H., ACAR ÇEVİK U., BOSTANCI H. E., Kaya O., KOÇYİĞİT Ü. M.

ChemistrySelect , cilt.8, sa.27, 2023 (SCI-Expanded)

21. Synthesis, Anticancer Activity and Carbonic Anhydrase Inhibitory Activity of new Thiadiazole-hydrazone Derivatives

Bostancı H. E., ÇEVİK U.

Cumhuriyet Science Journal , cilt.44, sa.2, ss.258-262, 2023 (Hakemli Dergi)

22. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents

ACAR ÇEVİK U., ÇELİK İ., PASHAYEVA L., FATULLAYEV H., BOSTANCI H. E., ÖZKAY Y., et al.

Archiv der Pharmazie , cilt.356, sa.5, 2023 (SCI-Expanded)

23. New imidazole derivatives as aromatase inhibitor: Design, synthesis, biological activity, molecular docking, and computational ADME-Tox studies

Çetiner G., ACAR ÇEVİK U., ÇELİK İ., BOSTANCI H. E., ÖZKAY Y., KAPLANCIKLI Z. A.

Journal of Molecular Structure , cilt.1278, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Synthesis of Benzimidazole-1,2,4-triazole Derivatives as Potential Antifungal Agents Targeting 14α-Demethylase

Güzel E., ACAR ÇEVİK U., EVREN A. E., BOSTANCI H. E., GÜL Ü. D., KAYİŞ U., et al.

ACS Omega , cilt.8, sa.4, ss.4369-4384, 2023 (SCI-Expanded)

25. Synthesis and Molecular Docking of New N-Acyl Hydrazones-Benzimidazole as hCA I and II Inhibitors.

Küçükoğlu K., Çevik U. A., Nadaroglu H., Celik I., Işık A., Bostancı H. E., et al.

Medicinal chemistry (Shariqah (United Arab Emirates)) , cilt.19, ss.485-494, 2023 (SCI-Expanded)

26. Synthesis, and docking studies of novel tetrazole-S-alkyl derivatives as antimicrobial agents

ACAR ÇEVİK U., ÇELİK İ., Işık A., GÜL Ü. D., Bayazıt G., BOSTANCI H. E., et al.

Phosphorus, Sulfur and Silicon and the Related Elements , cilt.198, sa.2, ss.137-144, 2023 (SCI-Expanded)

27. Synthesis, biological evaluation and in silico studies of novel thiadiazole-hydrazone derivatives for carbonic anhydrase inhibitory and anticancer activities

BOSTANCI H. E., ÇEVİK U., Kapavarapu R., Güldiken Y., Inan Z. D., Güler Ö., et al.

SAR and QSAR in Environmental Research , cilt.34, sa.7, ss.543-567, 2023 (SCI-Expanded)

28. Benzimidazole-hydrazone derivatives: Synthesis, in vitro anticancer, antimicrobial, antioxidant activities, in silico DFT and ADMET studies

IŞIK A., ACAR ÇEVİK U., ÇELİK İ., BOSTANCI H. E., Karayel A., Gündoğdu G., et al.

Journal of Molecular Structure , cilt.1270, 2022 (SCI-Expanded)

29. Benzimidazol-Tiyadiazol Türevlerinin Sentezi, Karakterizasyonu, Antioksidan ve Antikanser Çalışmaları

BOSTANCI H. E., ACAR ÇEVİK U.

Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi , cilt.9, sa.2, ss.783-790, 2022 (Hakemli Dergi)

30. Synthesis, Molecular Docking, Dynamics, Quantum-Chemical Computation, and Antimicrobial Activity Studies of Some New Benzimidazole–Thiadiazole Hybrids

Çelik İ., Acar Çevik U., Karayel A., Işık A., Kayış U., Gül Ü. D., et al.

ACS OMEGA , cilt.1, sa.1, ss.1-2, 2022 (SCI-Expanded)

31. Design and Synthesis of Imidazole Derivatives as Anticancer Agents and Potential Aromatase Inhibitors

BOSTANCI H. E., ACAR ÇEVİK U.

CUMHURIYET SCIENCE JOURNAL , cilt.43, 2022 (Hakemli Dergi)

32. Synthesis and Characterization of Novel Calix[4]arene Schiff Base Derivatives and Cytotoxicity Effect Evaluation on Cancer Cell Lines

Işık A., UÇAR ÇİFÇİ K., BOSTANCI H. E., TUTAR Y., KOÇAK A., YILMAZ M.

CUMHURIYET SCIENCE JOURNAL , cilt.43, 2022 (Hakemli Dergi)

33. Design, synthesis and molecular docking studies of novel benzimidazole-1,3,4-oxadiazole hybrids for their carbonic anhydrase inhibitory and antioxidant effects

Kucukoglu K., ÇEVİK U. A., NADAROĞLU H., ÇELİK İ., Isik A., BOSTANCI H. E., et al.

MEDICINAL CHEMISTRY RESEARCH , cilt.31, sa.10, ss.1771-1782, 2022 (SCI-Expanded)

34. Evaluation of the effects of newly synthesized metallophthalocyanines on breast cancer cell lines with photodynamic therapy

BOSTANCI H. E., Bilgiçli A. T., Güzel E., Günsel A., Hepokur C., ÇİMEN B., et al.

Dalton Transactions , cilt.51, sa.41, ss.15996-16008, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

35. Synthesis, molecular modeling and evaluation of anticancer activities of some 1-substituted-4-phenyl piperazine derivatives

ALAGÖZ M. A., ÖZDEMİR Z., HEPOKUR C., BOSTANCI H. E., ÖNKOL T.

Macedonian Pharmaceutical Bulletin , cilt.66, sa.1, ss.53-54, 2020 (Hakemli Dergi)

36. Peripheral blood mononuclear cell microRNAs in coronary artery disease

Sanlialp M., Dodurga Y., Uludag B., Alihanoglu Y., Enli Y., Secme M., et al.

JOURNAL OF CELLULAR BIOCHEMISTRY , cilt.121, sa.4, ss.3005-3009, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

37. Increased urinary 6-hydroxymelatoninsulfate levels in attention deficit hyperactivity disorder diagnosed children and adolescent

Buber A., Cakaloz B., Isildar Y., Unlu G., BOSTANCI H. E., AYBEK H., et al.

NEUROSCIENCE LETTERS , cilt.617, ss.195-200, 2016 (SCI-Expanded)

38. microRNA-143 and-223 in obesity

Kilic I. D., Dodurga Y., Uludag B., Alihanoglu Y. I., Yildiz B. S., Enli Y., et al.

GENE , cilt.560, sa.2, ss.140-142, 2015 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 9

1. Investigation of the Relationship between the Chemical Structures and the Cytotoxicity of Some Maleic Anhydride-Containing Copolymers as Polymeric Drug Carriers

Karakuş G., BOSTANCI H. E., KAPLAN CAN H.

5th EBAT Congress, Antalya, Türkiye, 02 Kasım 2023, (Özet Bildiri)

2. The Effect of Vitamins on Oxidation in Experimentally Diabetes Conditioned Rats

BOSTANCI H. E., Başaran S.

33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2023), Türkiye, 2 - 07 Temmuz 2023, (Özet Bildiri)

3. INVESTIGATION OF SALVIA CADMICA’S ANTIOXIDANT PROPERTIES AND CYTOTOXIC PROPERTIES IN BREAST CANCER CELL LINE AND ITS APOPTOTIC INDUCTION

BOSTANCI H. E., Yatkın E., Bağcı E. R.

8th INTERNATIONAL ASIAN CONGRESS ON CONTEMPORARY SCIENCES, Türkiye, 5 - 07 Mayıs 2023, (Tam Metin Bildiri)

4. INVESTIGATION OF THE ANTIPROLIFERATIVE EFFECT OF SALVIA CADMICA ON COLON CANCER

BOSTANCI H. E., Doğanşah G., Bağcı E. R.

8th INTERNATIONAL ASIAN CONGRESS ON CONTEMPORARY SCIENCES, Türkiye, 5 - 07 Mayıs 2023, (Tam Metin Bildiri)

5. Investigation of Antiproliferative effect of Malva Sylvestris Extract on Breast Cancer and Antıoxidant Properties

BOSTANCI H. E., Gören M. F.

The 3rd International Cancer Days, Sivas, Türkiye, 15 Eylül 2022, (Tam Metin Bildiri)

6. investigation of the effects of BK369 compound on breast cancer

HEPOKUR C., BOSTANCI H. E., KUZU B., ALGÜL Ö.

8. İlaç kongresi, 27 Şubat - 01 Mart 2020 Sürdürülebilir Kalkınma

7. EFFECTS OF VITAMINS TO THE OXIDATION OF THE RATS ESTABLISHED EXPERIMENTAL DIABETES

BOSTANCI H. E., ROTA S. S.

GPSS, 11 - 13 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

8. Itakonik Asitli Akrilamid Polimerinin Prokainamid Hidroklorid Etken Maddesi ile Fiziksel Absorbsiyonu ve Karakterizasyonu

BOSTANCI H. E., MISIR S., HEPOKUR C., KARİPER İ. A., KARAKUŞ G., HEPOKUR A. İ.

3. İlaç Kimyası İlaç Etkin Maddesi Tasarımı, Sentezi Üretimi ve Standardizasyonu Kongresi, Türkiye, 20 - 22 Mart 2015, (Özet Bildiri)

9. İtakonik asitli akrilamid polimerinin prokainamid hidroklorid etken maddesi ile fiziksel absorbsiiyonu ve karakterizasyonu

BOSTANCI H. E., MISIR S., HEPOKUR C., KARİPER İ. A., Hepokur A. İ.

3. İlaç Kimya Kongresi, Antalya, Türkiye, 20 Mart 2015, (Özet Bildiri)

Kitaplar 4

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

222

H-İndeks (WoS)

Atıf (Scopus)

243

H-İndeks (Scopus)

Atıf (Sobiad)

H-İndeks (Sobiad)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler